BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38252673)

  • 1. Efficacy of short-course treatment for prevention of congenital transmission of Chagas disease: A retrospective cohort study.
    Moscatelli G; Moroni S; Ramírez JC; Warszatska B; Fernanda L; González N; Rabinovich A; Altcheh J
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011895. PubMed ID: 38252673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas.
    Fabbro DL; Danesi E; Olivera V; Codebó MO; Denner S; Heredia C; Streiger M; Sosa-Estani S
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3312. PubMed ID: 25411847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission.
    Sosa-Estani S; Cura E; Velazquez E; Yampotis C; Segura EL
    Rev Soc Bras Med Trop; 2009; 42(5):484-7. PubMed ID: 19967227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
    Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of congenital Chagas through treatment of girls and women of childbearing age.
    Moscatelli G; Moroni S; García-Bournissen F; Ballering G; Bisio M; Freilij H; Altcheh J
    Mem Inst Oswaldo Cruz; 2015 Jun; 110(4):507-9. PubMed ID: 25993401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Infected Women of Childbearing Age Prevents Congenital Trypanosoma cruzi Infection by Eliminating the Parasitemia Detected by PCR.
    Murcia L; Simón M; Carrilero B; Roig M; Segovia M
    J Infect Dis; 2017 May; 215(9):1452-1458. PubMed ID: 28201741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina.
    Blanco SB; Segura EL; Cura EN; Chuit R; Tulián L; Flores I; Garbarino G; Villalonga JF; Gürtler RE
    Trop Med Int Health; 2000 Apr; 5(4):293-301. PubMed ID: 10810029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of congenital Chagas disease by Benznidazole treatment in reproductive-age women. An observational study.
    Álvarez MG; Vigliano C; Lococo B; Bertocchi G; Viotti R
    Acta Trop; 2017 Oct; 174():149-152. PubMed ID: 28720492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
    Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y
    Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults.
    Falk N; Berenstein AJ; Moscatelli G; Moroni S; González N; Ballering G; Freilij H; Altcheh J
    Antimicrob Agents Chemother; 2022 May; 66(5):e0202121. PubMed ID: 35416710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
    Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
    J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
    Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
    Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction.
    Russomando G; de Tomassone MM; de Guillen I; Acosta N; Vera N; Almiron M; Candia N; Calcena MF; Figueredo A
    Am J Trop Med Hyg; 1998 Sep; 59(3):487-91. PubMed ID: 9749649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
    Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
    Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study.
    González NL; Moscatelli G; Moroni S; Ballering G; Jurado L; Falk N; Bochoeyer A; Goldsman A; Grippo M; Freilij H; Garcia Bournissen F; Chatelain E; Altcheh J
    PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010968. PubMed ID: 36534647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO).
    Altcheh J; Castro L; Dib JC; Grossmann U; Huang E; Moscatelli G; Pinto Rocha JJ; Ramírez TE;
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008912. PubMed ID: 33412557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital Chagas' disease: diagnostic and clinical aspects.
    Freilij H; Altcheh J
    Clin Infect Dis; 1995 Sep; 21(3):551-5. PubMed ID: 8527542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.